National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Insurance Coverage: Virginia
    Posted: 12/19/2002    Reviewed: 08/23/2005
Page Options
Print This Page  Print This Page
E-Mail This Document  E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

Denosumab May Help Prevent Bone Loss

Past Highlights

For more information about insurance coverage of clinical trial costs, see this feature's main page: States That Require Health Plans to Pay for Clinical Trial Costs.


Legislation: Senate Bill 1235, House Bill 871

Effective: July 1999

What clinical trials are covered?

Phase II, III, and IV cancer treatment trials, with Phase I trials covered on a case-by-case basis. Trial must be approved by one of the following:

  • National Cancer Institute (NCI)
  • NCI cooperative group or center
  • U.S. Food and Drug Administration
  • U.S. Department of Defense
  • U.S. Department of Veterans Affairs
  • An Institutional Review Board of a Virginia institution with a Multiple Project Assurance (MPA) from the U.S. Department of Health and Human Services' Office for Human Research Protections.

Who is required to pay?

Private insurers, specified managed care plans, and public employee health plans.

Other key provisions:

  • There is no clearly superior, noninvestigational alternative.
  • Data provide a reasonable expectation that the treatment will be at least as effective as the alternative.

Back to TopBack to Top


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov